International journal of surgery (London, England) · 2025
Causal mediation of immune cells in autoimmune liver diseases and oral cancer risk: a mendelian randomization study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Shen-Sui, Wang Wei-Li, Tian Xu-Dong, Gao Qiong, Wu Ya-Dong, Song Ju-Kun, Tang Zheng-Long
Аннотация
BACKGROUND: Emerging evidence suggests shared immune pathways between autoimmune liver diseases (AILDs) and oral cavity cancer (OCC), yet their causal interdependence remains poorly characterized.
METHODS: This study employs bidirectional Mendelian randomization (MR) with mediation analysis to systematically investigate the immunological interplay, particularly focusing on CD8 + T cell activity as potential mediator.
RESULTS: Genetically predicted PSC increased OCC risk (IVW OR = 1.00016, 95% CI: 1.00004-1.00028, p = 0.009); individuals in the top polygenic risk score (PRS) decile exhibited a 0.1% elevated OCC risk per 1-SD increase (OR = 1.001, 95% CI:1.0002-1.0020). After expanding OCC sample size (1,135 cases), PSC conferred higher OCC risk (OR = 1.1200, 95% CI:1.0100-1.2400, p = 0.029). PSC elevated CD8 + T cell absolute count (CD8 + T-cell AC) (OR = 1.05977-1.06767, p<0.001). After expanding the sample size of OCC (1135 cases), the risk of PSC and OCC was 1.12 (95% CI: 1.01-1.24, p = 0.0290). CD8 + T-cell AC mediated 12.47% of PSC's total effect on OCC (β = 0.01412, 95% CI: 0.0006-0.0276, p = 0.0401). No causal effects were observed for PBC, AIH, or reverse pathways.
CONCLUSIONS: This study provides the first genetic evidence establishing PSC as a causal risk factor for OCC via immune cell mediation, offering translational potential for enhanced surveillance, early detection protocols, and targeted immunotherapies in high-risk AILD patients.
METHODS: This study employs bidirectional Mendelian randomization (MR) with mediation analysis to systematically investigate the immunological interplay, particularly focusing on CD8 + T cell activity as potential mediator.
RESULTS: Genetically predicted PSC increased OCC risk (IVW OR = 1.00016, 95% CI: 1.00004-1.00028, p = 0.009); individuals in the top polygenic risk score (PRS) decile exhibited a 0.1% elevated OCC risk per 1-SD increase (OR = 1.001, 95% CI:1.0002-1.0020). After expanding OCC sample size (1,135 cases), PSC conferred higher OCC risk (OR = 1.1200, 95% CI:1.0100-1.2400, p = 0.029). PSC elevated CD8 + T cell absolute count (CD8 + T-cell AC) (OR = 1.05977-1.06767, p<0.001). After expanding the sample size of OCC (1135 cases), the risk of PSC and OCC was 1.12 (95% CI: 1.01-1.24, p = 0.0290). CD8 + T-cell AC mediated 12.47% of PSC's total effect on OCC (β = 0.01412, 95% CI: 0.0006-0.0276, p = 0.0401). No causal effects were observed for PBC, AIH, or reverse pathways.
CONCLUSIONS: This study provides the first genetic evidence establishing PSC as a causal risk factor for OCC via immune cell mediation, offering translational potential for enhanced surveillance, early detection protocols, and targeted immunotherapies in high-risk AILD patients.